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The Mouse S100A15 Ortholog Parallels Genomic
Organization, Structure, Gene Expression, and
Protein-Processing Pattern of the Human
S100A7/A15 Subfamily During Epidermal Maturation
Ronald Wolf1,2, Christopher J. Voscopoulos1, Peter C. FitzGerald1, Paul Goldsmith1, Christophe Cataisson1,
Michele Gunsior1, Markus Walz2, Thomas Ruzicka2 and Stuart H. Yuspa1
The calcium-binding proteins of the human S100A7/A15 (hS100A7/A15) subfamily are differentially expressed in
normal and pathological epidermis. The hS100A7 (psoriasin) and S100A15 reside in a chromosomal cluster of
highly similar paralogs. To exploit the power of mouse models for determining functions of gene products, the
corresponding S100A7/A15 ortholog was cloned and examined in murine skin. The single mouse S100A15
(mS100A15) gene encodes a protein of 104 amino acids with a predicted molecular weight of 12,870 Da and two
EF-hand calcium binding sites. Using gene-specific primers and specific antibodies, expression of mS100A15 in
both skin and isolated keratinocytes is confined to differentiating granular and cornified epidermal cells.
Immunoblotting of epidermal extracts revealed a series of high molecular weight bands that are also recognized
by an antibody for transglutaminase-mediated protein crosslinks. mS100A15 expression is upregulated in
cultured keratinocytes induced to differentiate by calcium or phorbol esters. Maximal induction occurs
concordantly with expression of late differentiation markers. Induction is enhanced in keratinocytes
overexpressing protein kinase Ca and is dependent on activator protein-1 transcription factors. The regulation,
expression pattern and crosslinking of mS100A15 are consistent with the characteristics of the human orthologs,
providing a valid surrogate model to study changes in these proteins associated with cutaneous pathologies.
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INTRODUCTION
S100 proteins are small, calcium-binding proteins constitut-
ing the largest, multigenic family of calcium-binding EF-hand
proteins (Schafer and Heizmann, 1996; Donato, 2003). Many
S100 proteins show distinct tissue and cell-type-specific
expression patterns indicating local specification. In addition,
they undergo conformational changes in response to calcium
that contribute to their functional diversification. The proteins
of the S100A7/A15 family are of major interest because of
their differential expression and putative functional role
in epidermal cell maturation, tumorigenesis, and in-
flammation (Broome et al., 2003; Eckert et al., 2004;
Emberley et al., 2004; Marenholz et al., 2004). The human
calcium-binding protein S100A7 was first identified as
a protein upregulated in inflamed hyperplastic psoriatic
skin (Madsen et al., 1991). The highly homologous human
S100A15 (hS100A15) was recently identified in psoriasis
and found to also be upregulated in lesional skin (Wolf et al.,
2003). Genomic analysis of the S100A7 and S100A15
encoding chromosomal regions reveals that both must
have evolved by gene duplications during primate evolution,
forming an innate subfamily in man (Kulski et al., 2003).
The coexpression of the hS100A7 and hS100A15 in psoriasis
suggests that both proteins participate in keratinocyte
maturation, proliferation and/or skin inflammation. However,
the existence of two highly similar paralogs (490% identity)
sets certain limits in discriminating between them when
coregulated. Furthermore, little is known about the functional
role of the S100A7/A15 proteins in cutaneous pathology, yet
they are frequently dysregulated in a variety of pathological
conditions including cutaneous cancer. In order to establish a
valid model for understanding the functions of S100A7/A15
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in the epidermis, we initiated a study to characterize the
murine ortholog of the hS100A7/A15 subfamily and compare
its properties to those known for the human genes and
proteins.
RESULTS
Cloning and characterization of the mouse S100A15
Sequence alignment of the hS100A15 cDNA to a mouse
genomic contig (accession no.: NW_000191.1; now UCSC
mm6) identified three exon-corresponding matches. Appro-
priate gene-spanning primers were designed, which allowed
PCR amplifying of the predicted mouse transcript of cDNA-
derived from adult normal murine skin.
The mouse S100A15 (mS100A15) transcript aligned to a
genomic region of 1,329 nucleotide (nt) in total and is
organized in three exons and two introns with exon/intron
boundaries following the GT-AG rule (Figure S1a). Exon 1 is
untranslated, the translation is initiated within exon 2 and
terminated in exon 3 spanning an open reading frame of
327 nt (nt 111–437). The open reading frame translates into a
characteristic S100 protein sequence of 109 amino acids (aa),
with a calculated molecular weight of 12,870 Da and a
predicted pI of 6.18. The deduced mS100A15 protein
sequence contains two helix–loop–helix motifs corresponding
to two EF-hand calcium binding sites, which both are typical
for S100 proteins (Figure S1b): a variant S100-specific motif at
the N-terminus (aa 06–49) and a conserved, canonical site at
the C-terminus (aa 57–85). Furthermore, potential transgluta-
minase-reactive glutamine (Q12, 54, 72, 92, 96) and lysine
residues (K27, 36, 84, 87) are found throughout the entire
protein sequence. The genomic and the mRNA S100A15
sequence entries are available under GenBank accession
nos.: AY465109–AY465110.
In mice, hybridization of a specific mS100A15 probe to
digested genomic DNA led to a restriction pattern (Figure
S2a) that was reconstructed as a single genomic match
(Figure S2b). Blast alignment of the sequenced cDNA also
mapped the mS100A15 to a single genomic region on
chromosome 3qF1 (Figure 1a) within the murine equivalent
of the human epidermal differentiation complex. The
positioning and directionality of most of the S100 genes is
highly conserved among the two species. However, multiple
copies of genes similar to S100A15 are found in human that
vary in orientation (Figure 1a) participating in a cluster of
highly similar paralogs forming an innate S100A7/A15
subfamily among the hS100 proteins (Figure 1b). In contrast,
genomic and phylogenetic human–mouse comparisons for
other S100 members showed a single match (Figure 1a and
b). Based on the multiple protein sequence comparison used
to generate the phylogenetic tree, there is a lower degree of
identity (31%) between the mS100A15 and its best human
match (S100A15) than there is between the other mS100
genes and their human orthologs (average 84%, with a range
of 53–97%).
Characterization of the mS100A15 antibody 3961
To generate specific antibodies, we immunized rabbits with a
peptide specific for the S100A15 C-terminal sequence.
Western blot analysis of the peptide-purified antibody 3961
stained a low molecular weight band in keratinocyte lysates
at about the level of the recombinant monomer protein
(Figure 2a and b arrow), whereas related recombinant S100
proteins were not detected. Several higher molecular bands
represent uncleaved fusion protein in the recombinant
mS100A15 lane. Longer exposure of the membrane added
a ladder of highmolecular weight bands in the lysate
(Figure 2b, asterisk). Staining of proteins pulled down with
the mS100A15 antibody revealed a number of faint high
molecular weight bands (data not shown), and a main low
molecular band (monomer) at low exposure (Figure 2c). Both,
the low and high molecular bands were blocked by
increasing molar concentrations of the S100A15-specific
peptide (Figure 2b). Accordingly, the epidermal staining of
newborn skin diminished when the antibody was pre-
incubated with blocking peptide as demonstrated by
immunohistochemistry (Figure 2d).
Regulation and crosslinking of mS100A15 during epidermal
maturation
To investigate the distribution of the S100A15 in skin, we
analyzed newborn mouse skin by immunostaining. In new-
born skin, mS100A15 was localized in the differentiated
layers of the interfollicular epidermis and hair follicles (Figure
2d). In the dermis, the muscularis mucosae layer stained
mS100A15 positive. Immunofluorescence double staining
with markers of basal cells (Keratin 5) and spinous cells
(Keratin 10) indicated S100A15 is localized to the epidermal
granular and cornified layers (Figure 3a and b) and to the
maturing cells of the hair follicle.
To confirm the mS100A15 distribution, dissociated
newborn mouse skin keratinocytes were density separated
into their compartments based on buoyancy in Percol. Dense
basal cell and buoyant differentiated cells (Figure 3c and
d) were isolated and lysates subjected to immunoblotting.
mS100A15 was mainly found in the differentiated
cell population (Figure 3e, dp, ds). Interestingly, the
mS100A15 monomer was detected in the detergent-soluble
fraction (ds, arrow) of differentiated keratinocytes (Figure 3d),
whereas immunoreactive high molecular weight complexes
were found among the corresponding detergent-insoluble
fraction (dp, asterisk) after solubilization with SDS. Further-
more, identical migratory high molecular weight bands
reacted with an antibody for transglutaminase-mediated
protein crosslinks concordant with potential tran-
glutaminase-reactive sites within the mS100A15 protein
sequence.
In cultured keratinocytes, stimulation of transglutaminase
activity by calcium led to an increase of mS100A15
immunoreactive high molecular weight protein complexes
(Figure 4a and b, lanes 1 and 2), which were also recognized
by the antibody for transglutaminase-mediated protein cross-
links as used before (data not shown, compare Figure 3e). The
intensities of these high molecular bands attenuated when
co-treated with calcium and a competitive transglutaminase
inhibitor (HPB-2) in favor of the mS100A15 monomer (Figure
4a and b, lane 3).
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Regulation of mS100A15 transcripts during epidermal
differentiation in vitro
To characterize the S100A15 regulation during epidermal
maturation, murine keratinocytes were induced to differenti-
ate by elevating extracellular calcium. In this model at
0.12 mM calcium, mS100A15 is time- and dose-dependently
upregulated and temporally induced with the late differentia-
tion marker loricrin (Figure 5). At higher calcium of 1.2 mM,
induction is more rapid as has also been reported for
differentiation markers (Yuspa et al., 1989). The calcium-
mediated induction of mS100A15 transcripts can be blocked
by inhibition of protein kinase C (PKC) activity, a known
downstream signaling pathway in epidermal differentiation
(Figure 6a, left panel; Denning et al., 1995).
Phorbol esters also induce epidermal maturation through
direct activation of PKC. Similar to calcium, the PKC activator
12-O-tetradecanoylphorbol-13-acetate (TPA) induced
mS100A15 expression, and this was also blocked by the
PKC inhibitor Go¨6976 (Figure 6a, right panel). The induction
of mS100A15 by direct PKC activation was more rapid than
calcium-mediated induction and was dependent on TPA dose
(Figure 6b). PKCa is a major isoform regulating expression of
late epidermal differentiation markers, and we have gener-
ated transgenic mice with K5-targeted expression of this PKC
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Figure 1. Comparative genomic map and unrooted phylogenetic tree of human and mS100 members. (a) Position and orientation (arrows) of S100 genes on
human chromosome 1q21 and mouse chromosome 3F1–F2 (epidermal differentiation complex) corresponding to National Center for Biotechnology
Information-annotated genome sequences (human, May 2004, UCSC hg 17, build 35; mouse, March 2005, UCSC mm6, build 34). The S1007d/e genes are
predicted non-coding (bold). (b) The tree was constructed via a neighbor-joining method and the results of the bootstrap confidence levels of reliability
(1,000 repetitions) are indicated at each node. In this tree mouse and hS100 orthologs cluster together, and we note that the paralogs within the hS100A7/A15
subfamily cluster with its single mS100A15 ortholog. At the time when gene duplication in human was reported, S100A7 was the only paralog known, and the
gene duplicates had subsequently been named S100A7a–e (Kulski et al., 2003). Apart from the identified human paralogs S100A15 (S100A7a) and S100A7
(S100A7c), S100A7b is predicted to be coding and was also included in the analysis. According to HUGO guidelines, paralogs should not be designated
as ‘‘-like genes’’, therefore the recently suggested ‘‘S100A7-like’’ nomenclature for the hS100A7/A15 paralogs is not included (Marenholz et al., 2004).
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isoform to the epidermis (Denning et al., 1995; Cataisson
et al., 2003b). When K5-PKCa keratinocytes were isolated
and cultured, baseline expression of mS100A15 was elevated
(Figure 6c). Furthermore, elevating calcium in these cultures
substantially accelerated and enhanced the expression of the
mS100A15 compared with FVB/N (FVB) controls. Similarly,
direct activation of PKC by TPA amplified transcription of
mS100A15 in PKCa transgenic keratinocytes and sustained
the expression time (Figure 6d).
The two major transcription factor pathways activator
protein-1 (AP-1) and NF-kB play an important part in
regulating keratinocyte maturation, and both are also
regulated by PKCa (Cataisson et al., 2003a; Banno et al.,
2005; Cataisson et al., 2005). Inhibition of the NF-kB
signaling pathway by transduction of keratinocytes with IkBa
super-repressor (IkBasr) adenovirus did not effect either the
calcium- or TPA-mediated mS100A15 induction in these
cells (Figure 6e and f). In contrast, introduction of an AP-1
dominant-negative molecule (A-FOS) by adenoviral trans-
duction-abolished basal and both calcium- and TPA-induced
mS100A15 levels. Collectively, these results identify
mS100A15 as a transcriptional target downstream of PKCa in
differentiating keratinocytes consistent with AP-1-dependent
regulation of other S100 proteins reported previously
(Gebhardt et al., 2002).
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Figure 2. Characterization of the mS100A15 antibody 3961. (a, b)
Recombinant mS100A8, S100A9, S100A15 (50 ng/lane), and mouse
keratinocyte lysate (20 mg/lane) were separated on a denaturing 12%
polyacrylamide gel, transferred to nitrocellulose, and incubated with 1 mg/ml
affinity-purified S100A15 antibody 3961. (a) Membrane was exposed for
7 seconds (b) or 15 seconds without and in the presence of cognate peptide
(as molar ratio of antibody:peptide). Arrow indicates the migration of the
mS100A15 monomer; higher molecular weight immunoreactive complexes
are indicated by the asterisk. The immunoreactive bands above the
recombinant S100A15 monomer represent uncleaved recombinant
MBP-mS100A15 fusion protein. (c) Primary mouse keratinocyte lysate was
immunoprecipitated with the mS100A15 antibody 3961, immunoprecipitated
(IP) beads were consecutively eluted (E1–E3), separated, and analyzed
with the antibody 3961. (d) Newborn mouse skin was fixed, processed,
and stained with the mS100A15 antibody 3961 without (left) and in the
presence (right) of mS100A15-specific blocking peptide (as molar ratio of
antibody:blocking peptide).
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Figure 3. Distribution and characterization of mS100A15 within the
epidermis stained with the mS100A15 antibody 3961. (a, b) Newborn mouse
skin was fixed, processed, and costained with the S100A15 antibody 3961
(red) and (a) Keratin 5 (green) or (b) Keratin 10 (green), the nuclei were stained
with DAPI (blue). (c–f) Keratinocytes of the epidermal layers of newborn
mouse skin were separated by density centrifugation. The lysate (b) of basal/
spinous keratinocyte fraction (c) and the soluble (ds) and dissolved pelleted
fraction (dp) of the differentiated keratinocytes (d) were separated on a
denaturing 12% polyacrylamide gel, transferred to nitrocellulose, and
incubated (e) with peptide-purified mS100A15 antibody 3961 (1 mg/ml) or an
antibody recognizing transglutaminase-mediated protein crosslinks (1:500).
The arrow indicates the migration of the S100A15 monomer; higher
molecular weight-immunoreactive complexes are indicated by the asterisk.
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Figure 4. Calcium-induced formation of mS100A15 high molecular weight
protein complexes is reduced by an inhibitor of transglutaminase activity in
cultured keratinocytes. (a) Immunoblot of soluble lysates of newborn murine
keratinocytes grown in 0.05 mM calcium (lane 1), treated with 1.2 mM calcium
(lane 2), and 1.2 mM calcium and transglutaminase inhibitor HPB-2 (lane 3),
and then stained with the mS100A15 antibody 3961. The arrow indicates the
migration of the mS100A15 monomer; high molecular weight-immunoreac-
tive complexes (multimers) are indicated by the asterisk. (b) Relative
mS100A15 expression of monomer and the sum of the indicated multimers
are plotted according to intensity from the blot on the left.
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DISCUSSION
This study characterizes the mS100A15 as an ortholog of the
hS100A7/A15 subfamily. The results indicate striking similar-
ities with their human counterparts in genomic organization,
protein sequence, expression, distribution, and regulation
during normal epidermal maturation, validating functional
studies utilizing the mouse model.
Phylogenetic analysis assigned most members of the
mS100 family to its single human counterpart, whereas the
mS100A15 clustered with the group of the hS100 members
indicating this mouse gene is likely to be close to the
ancestral gene for all of these paralogs (S100A7/A15
subfamily; Figure 1b). Consistent with these findings, both
experimental Southern blot analysis (Figure S2) and compu-
tational genomic Blast analysis (Figure 1a) indicate only a
single genomic copy exists in mice. Primate and rodent
evolution has split after the appearance of the insectivores (Li
and Graur, 1991, and references therein). Thus, the
mS100A15 and its human paralogs represent successors from
a yet to be identified ancestor organism. Therefore, the exact
ancestral lineage of the hS100A7/A15 family members may
not be found from mouse–human genomic comparisons
alone. Also, since the S100A7/15 region undergoes chromo-
somal rearrangements and gene duplications, the otherwise
phylogenetic conserved gene orientation may not be useful
for determining the primordial member of the S100A7/15
family (Figure 1a; Kulski et al., 2003; Marenholz et al., 2004).
However, the single gene copy in mouse suggests that the
murine gene is closer to this particular ancestor than each of
the human paralogs that derived later during primate
evolution (Kulski et al., 2003). Hence, the mouse gene could
represent characteristics common to all of its human
successors.
In human, a total of five genomic S100A7/A15-like copies
have evolved, of which three are predicted to be functional
(Kulski et al., 2003). Expression of two of the three has been
described (S100A7, S100A15; Madsen et al., 1991; Wolf
et al., 2003). For the mouse ortholog, aa analysis predicted an
N-terminal calcium-binding motif, which is also found in the
hS100A15 but not in the hS100A7 (Wolf et al., 2003). In
contrast, a full Jab-1-binding motif is predicted for both the
mouse ancestor and the hS100A7 but not for the hS100A15
(Webb et al., 2005). Phylogenetic analyses showed the
mouse ancestor to be most related to S100A7 and S100A15
among the human paralogs (Figure 1b). However, the slightly
better alignment between the mouse gene and the hS100A15
might have favored the re-annotation of the mouse gene
‘‘S100A7 like’’ (XM_143311) to ‘‘S100A15 like’’
(XM_356221) by National Center for Biotechnology Inform-
ation. Accordingly, we refer the mouse ortholog as in
S100A15 (AY465109, NM_199422).
To produce polyclonal antibodies, we immunized rabbits
with a mS100A15-specific peptide. Proving specificity, the
resulting peptide-purified antibody 3961 detected the re-
combinant S100A15 protein, but not related S100 proteins.
Further, antibody competition with the corresponding pep-
tide blocked the recognition of the mS100A15 protein in both
immunoblot analysis and immunohistochemistry (Figure 2b
and d). Staining of keratinocyte lysate showed a correspond-
ing low molecular weight band, which, however, appeared
slightly higher than that of the recombinant mS100A15
(Figure 2a). Post-translational modifications, particularly
intramolecular crosslinking by disulfide bonds, can retard
the gel separation of S100 proteins, suggesting that these
could also have occurred in mS100A15 monomers (Figure
S1b: cysteine6, 74, 88, 98, 102) when natively expressed in
keratinocytes (Calissano et al., 1976). Furthermore, cross-
linking of S100 monomers to themselves or others can lead to
the formation of multimers (Ruse et al., 2001; Broome et al.,
2003). Keratinocyte lysate also stained for mS100A15-
positive multimers, which could be competed by the
immunizing peptide, indicating the presence of mS100A15.
High molecular weight protein complexes are assembled
by transglutaminase-mediated crosslinking to participate in
the cornified envelope of differentiated layers of the human
and mouse epidermis (Hennings et al., 1980; Eckert et al.,
2005). Potential transglutaminase-reactive residues are pre-
dicted in the mS100A15 protein sequence (Figure S1b;
Birckbichler and Patterson, 1980). Analysis of isolated
differentiated keratinocytes reveals detergent-insoluble
mS100A15-positive multimers that were also recognized by
an antibody for transglutaminase-mediated protein crosslinks
(Figure 3). In cultured keratinocytes, mS100A15 high
molecular weight complexes form during differentiation
simulated by calcium switch (Figure 4). The induced
S100A15 multimer formation could be attenuated by using
a substrate-competitive transglutaminase inhibitor, and the
simultaneous increase of the mS100A15 monomer further
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indicates that the protein is a transglutaminase substrate.
Together, our data show that these multimers are likely to
form by covalent attachment of the mS100A15 monomer to
other proteins by transglutaminase. Heteromultimers, formed
by transglutaminase, have been reported for the hS100A7 and
high molecular weight complexes were also detected for the
hS100A15 (unpublished data), suggesting that this character-
istic is shared among the mouse and human orthologs (Ruse
et al., 2001).
mS100A15-containing multimers were mainly detected in
isolated differentiated keratinocytes and antibody staining
localized the protein to the differentiating compartment in
skin sections (Figure 3), indicating these high molecular
weight complexes contribute to the suprabasal granular and
cornified layers (Figure 2). mS100A15 staining is also
detected in differentiating cells of the hair follicles, a location
also positive in human skin stained with some of the
antibodies against hS100A7 (Martinsson et al., 2005). The
expression of the mS100A15 in skin maturation could be
mirrored in keratinocytes that are induced to differentiate by
elevating extracellular calcium (Figure 5). The mS100A15 co-
regulation with late differentiation markers is in accordance
with the in situ staining pattern above Keratins 5 and 10 in the
newborn skin (compare Figure 3a and b). Calcium-mediated
signal transduction is highly complex in epidermal differ-
entiation and can involve the activation of protein kinases C
(PKC; Denning et al., 1995; Lee et al., 1997; Bikle et al.,
2001). Inhibition of PKC activity diminished the calcium-
induced mS100A15 expression, suggesting that PKC partici-
pates in that regulation of mS100A15 (Figure 6b). This is
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Student’s t-test versus contol. Newborn murine keratinocytes were treated (a) with 0.1% DMSO and with 1.2 mM calcium for 24 hours or 5 ng/ml TPA for 3 hours
as indicated. When used, PKC inhibitor Go¨6976 (5mM) is added 30 minutes before addition of test substance. (b) Cells were treated with TPA for the indicated
doses and time intervals. Newborn murine keratinocytes (WT) and K5-PKCa transgenic keratinocytes (K5-PKCa) were treated (c) with calcium for 24 hours or
(d) TPA for 3 hours. K5-PKCa transgenic keratinocytes were treated with (e) calcium for 24 hours or (f) TPA for 3 hours after transduction with adenoviral
A-cytomegalovirus (control), AP-1 dominant-negative (A-FOS), or IkBa super-repressor constructs (IkBasr), respectively. In parallel, AP-1- and NF-kB-regulated
genes have been used to validate the efficacy of the corresponding constructs (data not shown).
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further supported by induction of mS100A15 with direct PKC
activation by TPA paralleling the calcium effect (Figures 5
and 6b). However, particularly the calcium-stimulated
mS100A15 expression was not fully blocked by PKC
inhibition, suggesting that pathways other than PKC might
be involved. Several PKC isoforms are involved in keratino-
cyte maturation in which activation of the calcium-sensitive
PKCa is shown to regulate late differentiation marker
expression in an AP-1-dependent manner (Dlugosz and
Yuspa, 1994; Rutberg et al., 1996; Yang et al., 2003).
Compared with normal keratinocytes, the enhanced trans-
cription of S100A15 in calcium- and TPA-stimulated PKCa
transgenic keratinocytes (Figure 6c and d) indicates a
PKCa-mediated regulation of the mS100A15. Furthermore,
induction by elevated calcium or TPA requires AP-1
transcriptional activation but is independent of NF-kB
(Figure 6e and f). This regulation pattern is concordant with
expression and distribution of the mS100A15 in differentiated
layers of normal skin. In addition, the localization and
regulation of mS100A15 high molecular weight forms is also
consistent with PKC- and AP1-dependent transglutaminase
activity in differentiated keratinocytes (Dlugosz and Yuspa,
1994; Eckert and Welter, 1996). Thus, both expression and
processing are concordant functions during keratinocyte
maturation.
In human, both known counterparts, S100A7 and
S100A15, are found upregulated with disturbed calcium
homeostasis and premature late differentiation (psoriasis);
however, underlying regulatory mechanisms are under
investigation (Madsen et al., 1991; Wolf et al., 2003;
Martinsson et al., 2005). Pathways regulating S100A15 in
mice could help to elucidate the regulation and role of the
hS100A7/A15 paralogs in normal skin and disease. The
results presented in this study confirm that the mS100A15
represents the murine ortholog of the hS100A7/A15 sub-
family. This conclusion is supported by comparing genomic
organization and protein similarity across the species for
phylogenetic relationship. Furthermore, expression, distribu-
tion and regulation as well as post-translational crosslinking
of the mS100A15 by transglutaminase during normal
epidermal maturation are additional common features shared
with its human counterparts. Concordant with the assumed
role for its human successors in normal and disturbed
epidermal maturation, we conclude that the mS100A15 can
be used to study the role of the S100A7/A15 family in
hyperplastic and other cutaneous diseases using the mouse
model.
MATERIALS AND METHODS
All the Materials and Methods used have been approved by the
National Cancer Institute.
Synthesis, cloning, and sequence analysis of the mS100A15
cDNA
Freshly dissected mouse tissues were snap frozen in liquid
nitrogen and homogenized in TRIZOLs reagent (Invitrogen,
Karlsruhe, Germany) using a dismembrator (Braun, Melsungen,
Germany).
Total RNA (1 mg) was denaturated at 701C for 10 minutes and
first-strand cDNA was synthesized in a 20 ml reaction solution
containing 4ml 5 reverse transcription buffer (Invitrogen), 25 ng/ml
oligo-dT primers, 0.5 mM dNTPs, 10 mM dithiothreitol, 40 U RNasin
(Promega, Mannheim, Germany) and 200 U Superscript III-Reverse
Transcriptase (Invitrogen) at 501C for 1 hour and 601C for 10
minutes.
PCR reactions (20 ml) contained 1ml of the reverse transcription
sample, 2ml 10 buffer (Qiagen, Hilden, Germany), 1.5 mM MgCl2,
0.2 mM dNTPs, diethyl pyrocarbonate-treated water, 2 U Taq
polymerase (Qiagen), and 0.1 mM of specific intron spanning primer
pairs. For amplification of the mS100A15 transcripts, primers were
based on the genomic sequence deposited in GenBank (clone RP1-
128L15, accession no.: AL591704): S100A15 – sense, exon 1:
50-ATCTCACTCATCCTTCTACTCGTG-30; S100A15 – antisense,
exon 3: 50-GAGCTAAGAGAGAAAGAGAGCAA-30.
The PCR conditions were 31 cycles at 941C for 1 minute, 561C for
1 minute, and 721C for 1 minute (þ time increment of 2 seconds/
cycle) followed by an additional extension step at 721C for
5 minutes. PCR products were separated on a 1.5% agarose gel,
extracted (QiaexII; Qiagen) and cloned into pCRII-TOPO (Invitro-
gen). Insert-containing plasmids were purified from transformed
E. coli Top10 cells (Invitrogen) using QIAprep-spin columns
(Qiagen) and sequenced with flanking M13-sequencing primers.
Southern blotting
Genomic mouse DNA was digested by restriction enzymes as
described in the individual experiment. Digested DNA per lane
(10 mg) was fractionated on a 1% agarose gel and transferred onto a
Hybond-Nþ membrane (Amersham, Braunschweig, Germany). The
mS100A15 probe was generated by PCR under conditions described
above. The PCR fragments were radioactively labeled with the High
Prime DNA Labeling Kits (Roche, Mannheim, Germany) and
hybridized in DIG Easy hyb solutions (Roche) at 371C. The
autoradiographic signals were analyzed with a phosphoimager
(ImageQuant, Molecular dynamics, Heidelberg, Germany).
Cell culture and adenovirus transduction
Epidermal cells from newborn FVB/N mice were isolated and
cultured in Eagle’s medium with 8% fetal calf serum, 1% antibiotic,
and a calcium concentration of 0.05 mM as described (Dlugosz et al.,
1995). After 7 days, primary cultures were switched to medium with
various calcium, or TPA concentrations as indicated, and transglu-
taminase substrate inhibitor HPB-2 (syn. RS 71666, similar to RS
10823; Killackey et al., 1989). When used, transglutaminase
inhibitor was added 24 hours before calcium switch. Keratinocytes
were harvested into lysis buffer for protein analysis (Cell Signaling,
Beverly, MA) by SDS-PAGE and for RNA analysis (Quiagen,
Valencia, CA) by semiquantitative reverse transcription-PCR. For
certain experiments, the IkBasr (Guttridge et al., 1999) or A-FOS
(Olive et al., 1997; Bonovich et al., 2002) adenoviruses were
introduced into primary keratinocytes using an adenoviral construct
driven by a cytomegalovirus promoter and empty adenovirus was
used as control (A-cytomegalovirus). The cells were infected for
30 minutes in serum-free medium with a multiplicity of infection of
five viral particles/cell and 2.5 mg/ml of Polybrene (Sigma, St Louis,
MO) to enhance uptake. Serum-containing medium was added to
the cells for the next 24 hours after the infection.
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Semiquantitative PCR analysis
RNA was isolated from cultured cells (RNeasy, Qiagen) according to
the manufacturer’s instructions and reverse transcribed using Super-
script III. Transcript levels of mS100A15, Keratins 5 and 10, loricrin
(Roop et al., 1983) and 18S control (Ambion, Woodward, TX) were
optimized to the log-linear phase of the PCR amplification for each
set of primers. Quantification of fragments was based on two
different cycles within the log-linear phase. Amplicons were
subjected to agarose-gel electrophoresis (2%) and stained with
ethidium bromide. The density of the amplicons was measured by
integrating UV light of the stained bands using a digital camera
image analyzing system (Multianalyst, Biorad Laboratories, Her-
cules, CA), and expressed as the relative signal intensity normalized
by 18S expression (relative intensity).
mS100A15 antibody production, immunoprecipitation,
immunoblot analysis, and immunohistochemistry
Monospecific antisera to mS100A15 were prepared in rabbits by
injecting a synthetic peptide that corresponds to the carboxy-
terminal aa sequence of the deduced S100A15 protein (GenBank
accession no.: NP_955454). The rabbit antibodies were affinity
purified using the synthetic peptide coupled to Affigel-ISC (Biorad)
(Goldsmith et al., 1987). Primary mouse keratinocyte lysate was
immunoprecipitated with the S100A15 antibody 3961 using Seize X
protein A immunoprecipitated Kits (Pierce, Rockford, IL). Immuno-
precipitated beads were consecutively eluted, separated and
analyzed with the same antibody. Recombinant proteins were
generously provided by Philippe Tessier (Laval University, Quebec,
Canada; Vandal et al., 2003).
For immunoblot analysis, cultures were washed twice with PBS,
and total cell lysates prepared using 1% Triton-containing lysis buffer
(Cell Signalling). For some experiments, dissociated newborn mouse
keratinocytes were prepared and density separated in Percol as
described previously (Fischer et al., 1982). Upon centrifugation,
insoluble protein fractions were dissolved with an SDS containing
lysis buffer (5% SDS, 20% b-mercaptoethanol in 0.25 M Tris, pH 6.8;
Yuspa et al., 1989). Proteins were separated using a 12%
polyacrylamide gel, transferred to reinforced nitrocellulose mem-
brane and visualized by Ponceau stain. Filters were incubated with
blocking buffer (TBS, pH 7.4, with 5% milk, 0.1% Tween 20) for
30 minutes, primary antibody (anti-S100A15 3961, 1 mg/ml; anti-Ne
g-glutamyl lysine, 1:500; Abcam, Cambridge, MA; anti-b actin,
1:20,000; Chemicon, Temecula, CA) overnight, and secondary
antibody for 1 hour with several washes (TBS, pH 7.4, 0.1% Tween
20) between the incubations.
Immunohistochemistry was performed on serial 5 mm frozen
sections of skin from newborn FVB mice, fixed in acetone. The
sections were treated with 96% methanol and 4% hydrogen
peroxide to inhibit peroxidase activity, blocked in 10% normal goat
serum, and incubated overnight with mS100A15 3961 rabbit-
derived polyclonal antibody (5 mg/ml). Slides were then treated the
next day with biotinylated anti-rabbit IgG (Hþ L) (1:1,000), followed
by an avidin–biotin complex incubation (Elite Vectastain). Samples
were exposed using the Vector DAB Kit and mounted with mounting
medium. All reagents for immunostaining were from Vector
Laboratories, Burlington, CA. Serial dilution competition assays
were performed in the absence and presence of blocking peptide as
indicated to determine the optimal working concentration and
specificity of the primary mS100A15 antibody using both immuno-
histochemistry and immunoblot analysis.
For immunoflourescence, goat anti-rabbit Cy3 was used as a
secondary antibody to the mS100A15 3961 (Jackson Laboratory, Bar
Harbor, MI). If the sections were to be co-stained, Keratin 5–FITC and
Keratin 10–FITC were used (Covance, Richmond, CA). All sections
were nuclear stained with 4,6-diamidino-2-phenylindole (Sigma)
and mounted with mounting medium for immunofluorescence.
Bioinformatics
Genomic introns/exon structures were predicted using DIGIT,
Genescan, HMMgene, and NetGene2. Webcutter version 2 software
was used for identification of recognition sites for DNA restriction
enzymes within a 15,749 nt region flanking the mS100A15 gene
(NT_039234.3, nt 26,112,425–26,128,174). The ExPASy nucleotide
translation tool (Swiss Institute of Bioinformatics, Switzerland; http://
www.expasy.org/tools/dna.html) was used to translate cDNA in all
six open reading frames. For prediction of the protein consensus
pattern, profiles, structures, and potential post-translational mod-
ification, InterPro Scan, Hits, 3D-PSSM, and PSIPred were used,
available from Swiss Institute of Bioinformatics. The PromoterIn-
spector (Genomatix, Munich, Germany) was used for prediction of
transcription factor binding sites and typical promoters.
The aa sequences of the S100 families from mouse and human
were aligned using the program Tcoffee (version 2.11; Poirot et al.,
2004). The phylogenetic tree was constructed using ClustalW’s
(version 1.81; Thompson et al., 1994) Neighbor-joining method with
gap exclusion (Saitou and Nei, 1987). The reliability of the
phylogeny’s interior branches was tested by performing the bootstrap
method with 1,000 replications. The sequences used are listed in
Supplementary Material.
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